Načítá se...
Systemic Treatment Strategies for Patients with Hereditary Breast Cancer Syndromes
Hereditary breast cancer syndromes are associated with an increased risk of breast cancer and constitute a unique patient population, making up approximately 5%–10% of breast cancer cases in the United States. By virtue of the germline mutations that define these syndromes, invasive breast cancers i...
Uloženo v:
| Vydáno v: | Oncologist |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
AlphaMed Press
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5469585/ https://ncbi.nlm.nih.gov/pubmed/28469042 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0430 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|